Published on

CDSCO Manufacturing License for Chemical cold pack snakebite kit.

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

The Central Drugs Standard Control Organization (CDSCO) is the national regulatory body for pharmaceuticals and medical devices in India. Its primary role is to ensure the safety, efficacy, and quality of drugs, cosmetics, and medical devices distributed in the country. In alignment with this, the CDSCO is also responsible for issuing manufacturing licenses for medical devices, an essential procedure in the healthcare industry for maintaining high standards of safety and efficiency.

In today's discussion, our focus is on a medical device of critical importance in emergency scenarios - the Chemical Cold Pack Snakebite Kit. A first-aid measure in treatment of snakebites, this device's significance is immeasurable. This guide will explore the CDSCO regulations, manufacturing process, and necessary license for the production of these snakebite kits. Find more information on CDSCO's official portal by visiting here.

What is a Chemical Cold Pack Snakebite Kit?

Often found in first aid kits, a Chemical Cold Pack Snakebite Kit is a medical device designed to provide immediate first-aid treatment in case of a snakebite. These snakebite kits contain tools that combine chemical elements to generate a cold pack, which can relieve swelling and slow venom spread until professional medical help is attained.

The Role of CDSCO in Medical Device Regulation

Established under the Department of Health and Family Welfare, the CDSCO has been instrumental in the development of medical device regulation in India. Its mission is to safeguard and enhance public health by ensuring the safety, efficacy and quality of drugs, cosmetics and medical devices.

A robust regulatory framework enables CDSCO to effectively oversee the manufacturing and distribution of medical devices. This includes the issuance of manufacturing licenses, conducting inspections and post-market surveillance, amongst other crucial responsibilities.

How to manufacture a Chemical Cold Pack Snakebite Kit

Just as with other Class D medical devices, the manufacturing of a Chemical Cold Pack Snakebite Kit requires strict adherence to approved procedures and quality standards. The device's production involves intricate processes that necessitate effective supervision to ensure safety and efficacy.

Fees for Manufacturing License for a Chemical Cold Pack Snakebite Kit

In accordance with the CDSCO's classification, a Chemical Cold Pack Snakebite Kit falls into Class D, attracting a manufacturing license fee of Rs. 50,000 and an additional fee of Rs. 1,000 per product under the MD9 license category.

Why is a Manufacturing License Necessary for a Chemical Cold Pack Snakebite Kit?

Primarily, obtaining a manufacturing license is a mandate. It is an affirmation of a device's quality and safety, ensuring that all production processes adhere to stipulated regulations. This is indispensable in the healthcare sector, where adherence to regulatory compliance cannot be compromised, and provides protection to consumers and patients from substandard products.

Steps to Obtain a CDSCO Manufacturing License for a Chemical Cold Pack Snakebite Kit

  1. Documentation: This includes Device Master File, Quality Management Certificate, Device Details, Site details, etc.
  2. Application Submission: This step involves submitting the requisite documents to the appropriate regulatory body.
  3. Evaluation and Inspection: Upon receipt of the application, an evaluation is conducted, followed by an inspection of the manufacturing site.
  4. License Approval: Once compliance with all requirements is confirmed, the manufacturing license is issued.

Frequently Asked Questions (FAQs)

Q. What is the risk class of a Chemical Cold Pack Snakebite Kit as per Medical Device Rules, 2017? A. The Chemical Cold Pack Snakebite Kit falls under Class D, the highest risk category.

Q. What license is needed to manufacture a Chemical Cold Pack Snakebite Kit? A. To manufacture a Chemical Cold Pack Snakebite Kit, an MD9 license is required.

Q. What is the fee for an MD9 license for a Chemical Cold Pack Snakebite Kit? A. The fee for an MD9 license to manufacture a Chemical Cold Pack Snakebite Kit is Rs. 50,000, with an additional fee of Rs. 1,000 per product.

Q. Who will issue the manufacturing license for a Chemical Cold Pack Snakebite Kit? A. For class C & D devices, including the Chemical Cold Pack Snakebite Kit, the manufacturing license is issued by the CDSCO HQ in New Delhi.

Q. Is repackaging of a Chemical Cold Pack Snakebite Kit considered manufacturing? A. Yes, as per the Drugs and Cosmetics Act's definition, repackaging of drugs, and by extension, medical devices, is considered manufacturing. Therefore, repackaging of a Chemical Cold Pack Snakebite Kit would require an MD9 license.

Conclusion

Obtaining a manufacturing license can feel like navigating a complex maze. Pharmadocx Consultants can help you in this journey with expert guidance. Find more information about these processes in this article. If you need consultation or assistance, reach out to us at Pharmadocx Consultants, call us directly at +91-7404557227, or send an email to [email protected]. Our professional team is committed to making the licensing process easier for you.

cdsco import license in india banner
cdsco manufacturing license in india banner